BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/22/2024 11:13:53 AM | Browse: 250 | Download: 1027
 |
Received |
|
2023-11-09 05:03 |
|
Peer-Review Started |
|
2023-11-09 05:05 |
|
First Decision by Editorial Office Director |
|
2023-12-08 02:36 |
|
Return for Revision |
|
2023-12-08 02:36 |
|
Revised |
|
2024-01-03 07:07 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-02-03 02:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-02-03 05:01 |
|
Articles in Press |
|
2024-02-03 05:01 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-03-13 07:05 |
|
Publish the Manuscript Online |
|
2024-03-22 11:13 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Etanercept-synthesizing adipose-derived stem cell secretome: A promising therapeutic option for inflammatory bowel disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Say-June Kim, Ok-Hee Kim, Ha-Eun Hong, Ji Hyeon Ju and Do Sang Lee |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) |
NRF-2021R1F1A1064566 |
|
| Corresponding Author |
Do Sang Lee, MD, PhD, Doctor, Doctor, Professor, Department of Surgery, Seoul St. Mary’s Hospital, College of Medicine, the Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul 06591, South Korea. dosangs@catholic.ac.kr |
| Key Words |
Adipose-derived stem cells; Etanercept; Inflammatory bowel disease; Secretome; Tumor necrosis factor-α |
| Core Tip |
This study explores a promising therapeutic strategy for treating inflammatory bowel disease (IBD) by harnessing the potential of a secretome derived from adipose-derived stem cells (ASCs) engineered to produce etanercept, a tumor necrosis factor-blocking drug. The findings demonstrate that the Etanercept-Secretome (Et-Sec) offers enhanced anti-inflammatory effects compared to traditional etanercept treatment. This superior therapeutic potential of the Et-Sec in IBD is attributed to its unique combination of etanercept synthesis and the intrinsic anti-inflammatory and immunomodulatory properties of ASC secretome, making it a promising candidate for advanced IBD therapy. |
| Publish Date |
2024-03-22 11:13 |
| Citation |
Kim SJ, Kim OH, Hong HE, Ju JH, Lee DS. Etanercept-synthesizing adipose-derived stem cell secretome: A promising therapeutic option for inflammatory bowel disease. World J Gastrointest Surg 2024; In press
|
| URL |
https://www.wjgnet.com/1948-9366/full/v16/i3/882.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v16.i3.882 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
